Intellectual Property Report: November 2019
ABA's Antitrust Magazine
The FDA’s and FTC’s Increased Focus on Generic Drug Competition Signals Enhanced Attention to REMS IssuesExternal Article
ABA’s Antitrust Health Care Chronicle
Moderator, Platform Regulation and Antitrust
Baker Botts, in partnership with Concurrences Review, will be hosting our annual complimentary Global Antitrust Seminar on Thursday, 20 September in Brussels.
Baker Botts will host a comprehensive CLE program in our Washington office on October 24, 2017.